Cerno<0x2019>s MassWorks calibration software for Agilent GC/MSD
25 November, 2009 | Agilent Technologies Australia Pty Ltd
Cerno Bioscience and Agilent Technologies have announced that they will jointly market Cerno’s MassWorks calibration software to Agilent gas chromatograph/mass spectrometer (GC/MSD) ChemStation users.
DKSH distribution agreement with DNR Imaging
23 November, 2009 | DKSH Australia Pty Ltd
DKSH has announced a distribution agreement with DNR Imaging, producer of UV imaging and camera systems for interpretation of diagnostic electrophoresis gels used in research and clinical diagnosis, complementing the electrophoresis instrumentation and consumables.
Lonza acquires Simbiosys Biowares' preclinical cell and molecular biology group
21 November, 2009 | Capsugel Australia Pty Ltd
Lonza has completed the acquisition of the preclinical cell and molecular biology assets of Simbiosys Biowares India, a biology outsourcing company, expanding its cell-biology platform.
Venom Science Cobra Venom Detection Kit
20 November, 2009 | Venom Supplies Pty Ltd
Venom Science has developed a Cobra Venom Detection Kit to assist in tracing the illegal use of cobra venom by racing trainers, previously difficult to detect. The test involves using specially treated venom antibodies which are labelled with markers that highlight the cobra venom when they come into contact with it.
Beckman Coulter Access Sex Hormone Binding Globulin (SHBG) assay
20 November, 2009 | Beckman Coulter Australia
Beckman Coulter has expanded its reproductive disease state management range with the Access Sex Hormone Binding Globulin (SHBG) assay for use in the differential diagnosis of conditions of chronic or excessive androgenic activity. The assay may also be used in conjunction with the Access Testosterone Assay to provide a calculated free androgen index1.
Lonza Potelligent CHOK1SV host cell line
20 November, 2009 | Capsugel Australia Pty Ltd
Potelligent CHOK1SV, a host cell line for manufacturing recombinant antibodies, combines BioWa’s glycosylation Potelligent technology with Lonza’s GS Gene Expression System and CHOK1SV.
AmpFISTR Identifiler Direct, Identifiler Plus and NGM PCR Amplification Kits
20 November, 2009 | Applied Biosystems Pty Ltd
Forensic DNA kits with chemistry reagents, the AmpFISTR Identifiler Direct, Identifiler Plus and NGM PCR Amplification Kits provide good performance, efficiency and data quality, enabling fast recovery of more DNA results from a wider range of samples.
Agilent SureSelect Human All Exon kit
20 November, 2009 | Agilent Technologies Australia Pty Ltd
The SureSelect Human All Exon Kit for the Applied Biosystems SOLiD System enables target enrichment prior to next-generation DNA sequencing.
SensiGene Cystic Fibrosis (CF) Carrier Screening Test
20 November, 2009 | Agena Bioscience Inc
The SensiGene Cystic Fibrosis (CF) Carrier Screening Test screens for 103 mutations and five variants, including the 23 mutations recommended by the American College of Medical Genetics (ACMG).
Enzo CELLestial fluorescent probes and labelling reagents
20 November, 2009 | Sapphire Bioscience
Enzo Life Sciences’ CELLestial fluorescent probes and labelling reagents for live cell analysis applications include reagents for detection of pH, calcium, chloride, zinc, membrane potential, ROS, GPCR, amyloid and lipid droplets.
Applied Biosystems SOLiD 3 Plus genomic analysis platform
20 November, 2009 | Life Technologies
Applied Biosystems’ SOLiD 3 Plus System, a genomic analysis platform, is designed for users working towards mainstream sequencing of personal genomes for clinical research and personalised medicine.
Labofix fixed volume micropipettes
20 November, 2009 | Sieper & Co Pty Ltd
Labofix fixed volume micropipettes complete the adjustable volume Pluripet ll range and 10 models offer a choice of volume range from 5 to 1000 µL.
Perkin Elmer EnSpire plate reader
20 November, 2009 | PerkinElmer (Australia) Pty Ltd
An expansion of the EnSpire Multilabel plate reader platform, EnSpire, provides users, including those working with primary or stem cells in cancer and neuropharmacology research, with improved assay performance and sensitivity.
Qiagen Influenza A/H1N1 test kit
20 November, 2009 | QIAGEN Pty Ltd
Qiagen has launch its Influenza A/H1N1 test and several updates to its activities in the global surveillance of the swine flu pandemic. The kit enables both the highly sensitive and specific detection of the novel Influenza A/H1N1 and all other known Influenza A and B virus strains. The test kit has been designed for use by governments and public health institutions.
PerkinElmer AutomatedGSP Genetic Screening Processor
20 November, 2009 | PerkinElmer (Australia) Pty Ltd
PerkinElmer has received the first 510(k) clearance from the US Food and Drug Administration for its automated GSP Genetic Screening Processor, used by public health laboratories as part of newborn screening programs.
